Celyad Oncology SA American Depositary Shares
CYAD
CYAD was delisted on the 18th of May, 2023.
8 hedge funds and large institutions have $7.74M invested in Celyad Oncology SA American Depositary Shares in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 2 closing their positions.
0.15% less ownership
Funds ownership: 4.84% → 4.68% (-0.15%)
11% less funds holding
Funds holding: 9 → 8 (-1)
32% less capital invested
Capital invested by funds: $11.4M → $7.74M (-$3.65M)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$18.2K |
| 2 |
II
Inspire Investing
Meridian,
Idaho
|
+$361 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$138K |
| 2 |
Jane Street
New York
|
-$117K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$62.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$18.7K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$11.2K |
CYAD Hedge Fund Activity: Q1 2020 in Review
8 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Celyad Oncology SA American Depositary Shares (CYAD) for Q1 2020, worth a combined $7.74M — down 32% from $11.4M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CYAD and 1 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 1 added.
The largest buyer was Morgan Stanley, adding an estimated $18.2K. The largest seller was Wells Fargo, cutting an estimated $138K.
- 8 institutional investors held Celyad Oncology SA American Depositary Shares (CYAD) as of Q1 2020, down from 9 in Q4 2019.
- Funds reported $7.74M of Celyad Oncology SA American Depositary Shares stock for Q1 2020, down 32% quarter-over-quarter.
- 1 fund opened new Celyad Oncology SA American Depositary Shares positions in Q1 2020 and 2 closed out, a net change of -1 holder.
- The largest Celyad Oncology SA American Depositary Shares buyer in Q1 2020 was Morgan Stanley, an estimated $18.2K added.
- The largest Celyad Oncology SA American Depositary Shares seller in Q1 2020 was Wells Fargo, an estimated $138K sold.
Based on aggregated 13F filings for Q1 2020.